Januvia - Pancreatitis, Pancreas, Hospitalization, Sitagliptin and Sideffects
Januvia (sitagliptin phosphate) and Janumet are type 2 diabetes drugs manufactured by Merck & Company. In September of 2009, the FDA warned that use of Januvia can result in an increased chance of acute pancreatitis. If you were prescribed Januvia or Janumet and experienced acute pancreatitis that required hospitalization, you may be entitled to monetary compensation.
Call SEGAL & LAX at 1-800-SMART-LAW to protect your rights, it may be the smartest call you make.